New publication out now, in which we used an ultra‐high field multimodal brain imaging approach, and showed that in occasional cannabis users, acute THC administration increased striatal glutamate and decreased functional connectivity in the reward system, which were associated with increases in subjective high and decreases in sustained attention. Such changes were absent in chronic… Continue reading Reduced responsiveness of the reward system is associated with tolerance to cannabis impairment in chronic users
We are offering a research intern position for a master student who is interested in the therapeutic effects of cannabis. We will conduct a field study in which we will study impulsivity in cannabis users. Specific activities consist of contacting coffee shops, recruiting participants, collecting data by means of questionnaires and neurocognitive tasks, data management,… Continue reading We are looking for a research intern, for a study on the therapeutic effects of cannabis
Dr. Kim Kuypers and Natasha Mason were invited to speak at and participate in an event in Helsinki, Finland, discussing research on the therapeutic potential and mechanisms of action of psilocybin and MDMA. The panel discussion has now been posted, and can be viewed here.
New study from our group assessed cognitive and subjective effects of a synthetic cannabinoid, JWH-018. Read coverage of the publication from Live Science.
07/03/2019. Jan Ramaekers spoke to Sander Hoogendoorn in his 3FM morning broadcast on the decision of the FDA to approve a ketamine derived depression drug. Listen to podcast here (scroll to 1 hr 51 min)